APA 6th Edition Štimac, G. i Kraus, O. (2006). Uloga upale u patogenezi karcinoma prostate. Medicus, 15 (2_UG infekcije), 283-290. Preuzeto s https://hrcak.srce.hr/18148
MLA 8th Edition Štimac, Goran i Ognjen Kraus. "Uloga upale u patogenezi karcinoma prostate." Medicus, vol. 15, br. 2_UG infekcije, 2006, str. 283-290. https://hrcak.srce.hr/18148. Citirano 16.01.2021.
Chicago 17th Edition Štimac, Goran i Ognjen Kraus. "Uloga upale u patogenezi karcinoma prostate." Medicus 15, br. 2_UG infekcije (2006): 283-290. https://hrcak.srce.hr/18148
Harvard Štimac, G., i Kraus, O. (2006). 'Uloga upale u patogenezi karcinoma prostate', Medicus, 15(2_UG infekcije), str. 283-290. Preuzeto s: https://hrcak.srce.hr/18148 (Datum pristupa: 16.01.2021.)
Vancouver Štimac G, Kraus O. Uloga upale u patogenezi karcinoma prostate. Medicus [Internet]. 2006 [pristupljeno 16.01.2021.];15(2_UG infekcije):283-290. Dostupno na: https://hrcak.srce.hr/18148
IEEE G. Štimac i O. Kraus, "Uloga upale u patogenezi karcinoma prostate", Medicus, vol.15, br. 2_UG infekcije, str. 283-290, 2006. [Online]. Dostupno na: https://hrcak.srce.hr/18148. [Citirano: 16.01.2021.]
Sažetak Prostate cancer continues to be a source of
considerable morbidity and mortality for aging men. In recent
publications there is emerging evidence that prostate inflammation
and/or infection may contribute to prostatic carcinogenesis.
Chronic subclinical inflammation is thought to incite carcinogenesis
by causing oxidative cell and genome damage, promoting
cellular turnover, and creating a tissue microenvironment that
can enhance cell replication, angiogenesis and tissue repair.
The molecular pathogenesis of prostate cancer has been characterized by somatic alterations of genes involved in defences
against inflammatory damage and in tissue recovery. In support
of this hypothesis, epidemiological data and population studies
have found an increased relative risk of prostate cancer in men
with a prior history of certain sexually transmitted infections or
prostatitis. Evidence from genetic and molecular studies also
support the hypothesis that prostate inflammation and/or infection
may be a cause of prostate cancer. These emerging insights
into chronic inflammation in the aetiology of prostate carcinogenesis
hold the promise of spawning new preventive strategies
for prostate cancer. The novel strategies in prostate cancer
chemoprevention include: 1/ antioxidants; 2/dietary antioxidants;
3/ anti-inflammatory drugs; 4/ prevention, detection and
therapy of sexually transmitted diseases. Recent literature on
the topic is reviewed and discussed.